|
The most significant study reported at the American Diabetes Association Scientific Sessions 2011 was certainly the BCG Human Clinical Trial Program results. Scott King*, President of Cerco Medical and fellow type-1, wrote the following review which may help shed some light on the impact this study will have on the life of anyone currently suffering [...]
|
Write a comment:
|